Search

everythinglearnresearchcommunity

for

Search:↓

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Some supplements may help reduce side effects of cancer treatments in pets.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

The cancer gene c-Myc increases harmful chemicals that damage DNA and can lead to cancer, but antioxidants can reduce this damage.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

The document suggests a possible link between hair loss and thyroid cancer, but doesn't provide definite proof.

Finasteride treats hair loss and reduces prostate cancer risk.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

PLD is an effective and safer alternative for treating breast cancer.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Some breast cancer chemotherapy can cause permanent hair loss.